Advertisement

Topics

Roche grants Dermira rights to interleukin-13 inhibitor

04:58 EDT 9 Aug 2017 | SmartBrief

Roche Holding and its Genentech subsidiary granted Dermira exclusive worldwide rights to its interleukin-13 inhibitor lebriki -More

Original Article: Roche grants Dermira rights to interleukin-13 inhibitor

NEXT ARTICLE

More From BioPortfolio on "Roche grants Dermira rights to interleukin-13 inhibitor"

Quick Search
Advertisement